Dr. Jörg Taubel will be attending the ESC Congress 2024, held from 30th August to 2nd September in London and online. This event is the world’s leading gathering for cardiovascular professionals, bringing together experts to explore ground breaking research, innovative technologies, and collaborative efforts aimed at reducing the burden of cardiovascular disease.

The ESC Congress 2024 will feature a comprehensive programme, including sessions on the latest advancements in cardiovascular medicine, discussions on clinical practice guidelines, and presentations of cutting-edge research. Attendees will include cardiologists, researchers, healthcare professionals, and industry leaders dedicated to advancing cardiovascular health and improving patient outcomes.

To find out more, click here.

Latest news

Von Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

First patient enrolled in telehealth study, the Pathway Study

February 25, 2025
The Pathway study is based on pioneering work during the pandemic between clinicians at Richmond Pharmacology and the National Amyloidosis Centre and aims...
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event